Genomics and Pharmacogenomics in Precision Medicine
The G20 Global Pharma Summit Series-Canada is a significant platform that brings together global leaders to discuss the future of healthcare. A key focus of this summit is the role of Genomics and Pharmacogenomics in Precision Medicine. Genomics, the study of all of a person's genes, and Pharmacogenomics, which examines how genes affect a person's response to drugs, are both crucial to the development of personalized treatments. Precision Medicine, which tailors treatments to individual patients based on their genetic makeup, is revolutionizing healthcare. By understanding a patient's genetic profile, doctors can prescribe medications and dosages that are most likely to be effective and least likely to cause side effects. The G20 Summit Series-Canada is an opportunity for global leaders to discuss how to integrate these cutting-edge technologies into healthcare systems worldwide, improving patient outcomes and reducing healthcare costs.
